Milad Alucozai’s Post

View profile for Milad Alucozai, graphic

Early-stage Investor | Startup Mentor | Serial Entrepreneur | Scientist | Board Member

For the past two weeks, I've been on the road, traveling across Canada and the US, giving talks on the intersection of AI and biotech. On a philosophical level, I feel fortunate to work in a field that is transforming biology from a specialized craft into a standardized engineering discipline. This shift is incredibly exciting. Just as mathematics revolutionized physics by uncovering nature's rules, AI and machine learning are now deconstructing biology into an engineering science. On a professional level, computational techniques are becoming central to biotech and healthcare startups, enabling close collaboration with domain experts. This transformation compels us to rethink resources, cloud infrastructure, access models, business models, and care paradigms. It's an exhilarating time for innovation and change. On a personal level, I’ve been overwhelmed by the large, diverse crowds of professionals attending my talks. They range from recent graduates from top-tier universities to mid-career and senior professionals from various technical and social backgrounds, all seriously considering careers in this space. Yes, there is hype. It takes effort to discern which companies are genuinely substantive. However, we have made significant progress, often led by quieter yet impactful startups. Yes, data silos are a problem. However, we are seeing leaders from government, academia, industry, and the private sector work together to unlock that access in an ethical and safe way to support advances. Stay tuned for some exciting news I'll be sharing soon :) #synbio #bioengineering #compbio #startups #biotech #venturecapital #artificalintelligence #AI #ArtificialIntelligence #Innovation #AICommunity #StartupEcosystem

  • No alternative text description for this image
Brian Reyland Jones

Vendre à l'international | Startup | Entreprise | Formation Commerciale | Levée de fonds - Seed & Série A | Développement Commercial | Pitch/ Storytelling Anglo-saxon 🤝 | BEST SELLING AUTHOR

1mo

Being on the road can be a lonely time, glad the public is sending a clear message :) Yes, it's not always the big claims by companies that can afford to make the most noise that more science and medicine forward... I'll DM you about a Medtech AI (Deeptech) startup that are humbly moving medicine forward I think you should hear what they're saying

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics